Nongenomic steroidal modulation of high-affinity serotonin transport

Biochimica et Biophysica Acta - Biomembranes

Volumn 1417, Issue 1, 1999, Pages 157-166

  Chang, Albert S ^a   Chang, Sharon M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Estradiol; Cocaine congener; Retinoid; Tamoxifen

Indexed keywords

BECLOMETASONE; COCAINE; COLECALCIFEROL; CORTICOSTERONE; CORTICOSTERONE DERIVATIVE; DEXAMETHASONE; DIETHYLSTILBESTROL; ESTRADIOL; ESTRADIOL 17 GLUCURONIDE; ESTRIOL; ESTRONE; IMIPRAMINE; LIOTHYRONINE; PREGNANE DERIVATIVE; PREGNENOLONE; PREGNENOLONE SULFATE; PROGESTERONE; RETINOIC ACID; STEROID; TAMOXIFEN; TESTOSTERONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION; TROPHOBLAST;

ANIMALS; CARRIER PROTEINS; CELL LINE; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; HUMANS; ION CHANNELS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; NERVE TISSUE PROTEINS; RECEPTORS, NEUROTRANSMITTER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TAMOXIFEN; TIME FACTORS;

EID: 0032994075     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(98)00255-7     Document Type: Article

References (44)

1. Kanner B.L., Schuldiner S. Mechanism of transport and storage of neurotransmitters. CRC Crit. Rev. Biochem. 22:1987;1-38.
2. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12:1991;141-147.
3. Wehling M., Christ M., Gerzer R. Aldosterone-specific membrane receptors and related rapid, non-genomic effects. Trends Pharmacol. Sci. 14:1993;1-4.
4. 3 in rat osteocarcinoma cells: Structure-function studies using ligand analogs. Endocrinology. 129:1991;1876-1884.
5. Valera S., Ballivet M., Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;9949-9953.
6. 125I-bovine serum albumin as a ligand. J. Neurochem. 54:1990;467-472.
7. Chang A.S., Frnka J.V., Chen D., Lam D.M.-K. Characterization of a genetically reconstituted high-affinity system for serotonin transport. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9611-9615.
8. Frnka J.V., Chang A.S., Lam D.M.-K. Pharmacological characteristics of high-affinity serotonin uptake systems established through gene transfer. J. Pharmacol. Exp. Ther. 256:1991;734-740.
9. Chang A.S., Chang S.M., Starnes D.M. SARs of serotonin transport: Relevance to nontricyclic antidepressant interactions. Eur. J. Pharmacol. 247:1993;239-248.
10. Chang A.S., Chang S.M., Starnes D.M., Schroeter S., Bauman A., Blakely R.D. Cloning and expression of the mouse serotonin transporter cDNA. Mol. Brain Res. 43:1996;185-192.
11. Cool D.R., Leibach F.H., Bhalla V.K., Mahesh V.B., Ganapathy V. Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J. Biol. Chem. 266:1991;15750-15757.
12. Michel M.C., Rother A., Hiemke C., Ghraf R. Inhibition of synaptosomal high affinity uptake of dopamine and serotonin by estrogen agonists and antagonists. Biochem. Pharmacol. 36:1987;3175-3180.
13. J.H. Clark, E.J. Peck Jr., Female Sex Steroids: Receptors and Function, Springer, New York, 1979.
14. Jordan V.C., Murphy C.S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocrine Rev. 11:1990;578-610.
15. Berthois Y., Katzenellenbogen J.A., Katzenellenbogen B.S. Phenol red in tissue culture is a weak estrogen: Studies concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. U.S.A. 83:1986;2496-2500.
16. Eckert R.L., Katzenellenbogen B.S. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res. 42:1982;139-144.
17. Myers C.L., Lazo J.S., Pitt B.R. Translocation of protein kinase C is associated with inhibition of 5-HT uptake by cultured endothelial cells. Am. J. Physiol. 257:1989;L253-L258.
18. Anderson G.M., Horne W.C. Activators of protein kinase C decrease serotonin transport in human platelets. Biochim. Biophys. Acta. 1137:1992;331-337.
19. O'Brian C.A., Liskamp R.M., Solomon D.H., Weinstein I.B. Inhibition of protein kinase C by tamoxifen. Cancer Res. 45:1985;2462-2465.
20. Su H.D., Mazzei G.J., Vogler W.R., Kuo J.F. Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary. Biochem. Pharmacol. 34:1985;3649-3653.
21. Meyer D.C., Quay W.B. Hypothalamic and suprachiasmatic uptake of serotonin in vitro: Twenty-four hour changes in male and proestrus female rats. Endocrinology. 98:1976;1160-1164.
22. 3H-labelled monoamines by hypothalamic tissue in vitro. Brain Res. 73:1974;321-331.
23. Wirz-Justice A., Hackman E., Lichtsteiner M. The effect of estradiol dipropionate and progesterone on monoamine uptake in rat brain. J. Neurochem. 22:1974;187-189.
24. Everitt B.J., Fuxe K., Hokfelt T., Jonsson G. Role of monoamines in the control by hormones of sexual receptivity in the female rat. J. Comp. Physiol. Psychol. 89:1975;556-572.
25. Kendall D.A., Tonge S.R. Effects of testosterone and ethinyloestradiol on the synthesis and uptake of noradrenaline and 5-hydroxytryptamine in rat hindbrain: Evidence for a presynaptic regulation of monoamine synthesis? Br. J. Pharmacol. 60:1977;310P-311P.
26. 3H]imipramine binding in male rats frontal cortex. Eur. J. Pharmacol. 197:1985;395-396.
27. Rehavi M., Sepcuti H., Weizman A. Up-regulation of imipramine binding and serotonin uptake by estradiol in female rat brain. Brain Res. 410:1987;135-139.
28. 3H]Imipramine binding in discrete brain areas is affected by castration in male rats. Brain Res. 496:1989;29-34.
29. 3H]paroxetine binding in the cerebral cortex and dorsal hippocampus of gonadectomized male and female rats. Brain Res. 601:1993;299-302.
30. A receptor. Trends Pharmacol. Sci. 8:1987;224-227.
31. A receptor. Brain Res. 526:1990;143-146.
32. Schumacher M. Rapid membrane effects of steroid hormones: An emerging concept in neuroendocrinology. Trends Neurosci. 13:1990;359-362.
33. 3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J. Steroid Biochem. Mol. Biol. 41:1992;231-240.
34. 3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses. J. Biol. Chem. 268:1993;13811-13819.
35. Bowlby M.R. Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol. 43:1993;813-819.
36. A receptor regulation: Chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites. Mol. Pharmacol. 44:1993;191-197.
37. Greenberg D.A., Carpenter C.L., Messing R.O. Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cell line. Cancer Res. 47:1987;70-74.
38. 2+ channel current in freshly isolated hippocampal CA1 neurons. Eur. J. Pharmacol. 202:1991;269-272.
39. Morley P., Whitfield J.F., Vanderhyden B.C., Tsang B.K., Schwartz J.-L. A new, nongenomic estrogen action: The rapid release of intracellular calcium. Endocrinology. 131:1992;1305-1312.
40. Baulieu E.-E., Robel P. Neurosteroids: A new brain function? J. Steroid Biochem. Mol. Biol. 37:1990;395-403.
41. Korneyev A., Guidotti A., Costa E. Regional and interspecies differences in brain progesterone metabolism. J. Neurochem. 61:1993;2041-2047.
42. Mellon S.H., Deschepper C.F. Neurosteroid biosynthesis: Genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 629:1993;283-292.
43. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
44. P.I. Musey, K. Wright, J.R.K. Preedy, D.C. Collins, Formation and metabolism of steroid conjugates: Effect of conjugation on excretion and tissue distribution, in: R. Hobkirk (Ed.), Steroid Biochemistry, vol. II, CRC Press, Boca Raton, 1979, pp. 81-131.